$DRNA News Article - Dicerna(TM) Announces the Presentation of Updated Data Demonstrating Utility of its Lead Compound DCR-PHXC in Treating Primary Hyperoxaluria Type 1 (PH1) and Type 2 (PH2)
https://marketwirenews.com/news-releases/dice...11802.html